| Active principles | Rating | Bibliogr. | Expand |
---|
1 | Japanese Encephalitis Vaccines | 100 | + | |
2 | Viral Vaccines | 22 | + | |
3 | Antibodies, Viral | 20 | + | |
4 | Acyclovir | 14 | + | |
5 | Viral Envelope Proteins | 10 | + | |
6 | Potassium Channels, Voltage-Gated | 9 | + | |
7 | Vaccines, Inactivated | 8 | + | |
8 | West Nile Virus Vaccines | 7 | + | |
9 | Antibodies, Neutralizing | 6 | + | |
10 | Vaccines, Attenuated | 6 | + | |
11 | Vidarabine | 5 | + | |
12 | Autoantibodies | 5 | + | |
13 | Sulfadiazine | 5 | + | |
14 | Hu Paraneoplastic Encephalomyelitis Antigens | 4 | + | |
15 | Vaccines, Synthetic | 4 | + | |
16 | Viral Proteins | 4 | + | |
17 | Immunoglobulins, Intravenous | 4 | + | |
18 | Glutamate Decarboxylase | 4 | + | |
19 | Viral Fusion Proteins | 4 | + | |
20 | Isatin | 3 | + | |
21 | Tilorone | 3 | + | |
22 | Immunoglobulin M | 3 | + | |
23 | Immunoglobulin G | 3 | + | |
24 | Viral Structural Proteins | 3 | + | |
25 | Vaccines, DNA | 3 | + | |
26 | DNA, Viral | 3 | + | |
27 | Measles Vaccine | 3 | + | |
28 | Purine Nucleosides | 2 | + | |
29 | Receptors, N-Methyl-D-Aspartate | 2 | + | |
30 | Poly U | 2 | + | |
31 | Pyrimethamine | 2 | + | |
32 | Arabinose | 2 | + | |
33 | Deoxyribonuclease HindIII | 2 | + | |
34 | Atovaquone | 2 | + | |
35 | Dengue Vaccines | 2 | + | |
36 | Viral Nonstructural Proteins | 2 | + | |
37 | Methylprednisolone | 2 | + | |
38 | Antibodies | 2 | + | |
39 | Poly G | 2 | + | |
40 | Naphthoquinones | 2 | + | |
41 | Cobra Cardiotoxin Proteins | 2 | + | |
42 | Inosine Nucleotides | 2 | + | |
43 | Trimethoprim-Sulfamethoxazole Combination | 2 | + | |
44 | Membrane Glycoproteins | 2 | + | |
45 | Idoxuridine | 2 | + | |
46 | Fenitrothion | 2 | + | |
47 | Ganciclovir | 1 | + | |
48 | Immune Sera | 1 | + | |
49 | Poly I-C | 1 | + | |
50 | Thiosemicarbazones | 1 | + | |
51 | Glycoproteins | 1 | + | |
52 | Influenza Vaccines | 1 | + | |
53 | Staphylococcal Protein A | 1 | + | |
54 | Viral Matrix Proteins | 1 | + | |
55 | Pentamidine | 1 | + | |
56 | Cytokines | 1 | + | |
57 | Nucleic Acids | 1 | + | |
58 | Nerve Tissue Proteins | 1 | + | |
59 | gamma-Globulins | 1 | + | |
60 | Chemokines, CX3C | 1 | + | |
61 | Methisazone | 1 | + | |
62 | Bromodeoxyuridine | 1 | + | |
63 | Gold Colloid | 1 | + | |
64 | Foscarnet | 1 | + | |
65 | Phosphonoacetic Acid | 1 | + | |
66 | Amantadine | 1 | + | |
67 | Butylated Hydroxyanisole | 1 | + | |
68 | Recombinant Fusion Proteins | 1 | + | |
69 | Transferrin-Binding Protein B | 1 | + | |
70 | Inulin | 1 | + | |
71 | Receptors, Lysophospholipid | 1 | + | |
72 | Clindamycin | 1 | + | |
73 | Interferon Type I | 1 | + | |
74 | Steroids | 1 | + | |
75 | Minocycline | 1 | + | |
76 | Antibodies, Monoclonal | 1 | + | |
77 | Peptides | 1 | + | |
78 | Oligonucleotides | 1 | + | |
79 | Vaccines | 1 | + | |
80 | Receptors, GABA-B | 1 | + | |
81 | Antibodies, Monoclonal, Murine-Derived | 1 | + | |
82 | Cytarabine | 1 | + | |
83 | Ribonucleosides | 1 | + | |
84 | Rabies Vaccines | 1 | + | |
85 | Recombinant Proteins | 1 | + | |
86 | Immunoglobulins | 1 | + | |
87 | Nucleocapsid Proteins | 1 | + | |
88 | Meningococcal Vaccines | 1 | + | |
89 | Antibodies, Protozoan | 1 | + | |
90 | Interferon-gamma | 1 | + | |
91 | Organophosphorus Compounds | 1 | + | |
92 | Bacterial Vaccines | 1 | + | |
93 | Dapsone | 1 | + | |
94 | Gene Products, pol | 1 | + | |
95 | Aerosols | 1 | + | |
96 | Zidovudine | 1 | + | |
97 | Glucocorticoids | 1 | + | |
98 | RNA, Viral | 1 | + | |